Aytu Biopharma, Inc financial data

Symbol
AYTU on Nasdaq
Location
7900 E. Union Avenue, Suite 920, Denver, CO
Fiscal year end
June 30
Latest financial report
Sep 23, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 99.8 % -0.73%
Quick Ratio 17.5 % -6.02%
Debt-to-equity 253 % +55.6%
Return On Equity -61.9 % +51.5%
Return On Assets -11.3 % +8.95%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9.91M shares +61.2%
Common Stock, Shares, Outstanding 8.98M shares +50.3%
Entity Public Float 7.24M USD -32.4%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 6.28M shares +13.4%
Weighted Average Number of Shares Outstanding, Diluted 8.2M shares +48.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 66.4M USD +1.84%
Cost of Revenue 41.2M USD -6.27%
Research and Development Expense 1.33M USD -52.1%
Selling and Marketing Expense 20.9M USD -5.33%
General and Administrative Expense 17.4M USD -12.9%
Operating Income (Loss) -7.83M USD -392%
Nonoperating Income (Expense) -7.71M USD -424%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -13.7M USD -32.4%
Income Tax Expense (Benefit) 437K USD
Net Income (Loss) Attributable to Parent -13.6M USD +14.4%
Earnings Per Share, Basic -2 USD/shares +24.5%
Earnings Per Share, Diluted 0.21 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 31M USD +54.7%
Accounts Receivable, after Allowance for Credit Loss, Current 31.2M USD +32.4%
Inventory, Net 11.4M USD -5.82%
Other Assets, Current 63.1M USD +4630%
Assets, Current 79.2M USD +27.9%
Property, Plant and Equipment, Net 532K USD -23.2%
Operating Lease, Right-of-Use Asset 1.06M USD +28%
Intangible Assets, Net (Excluding Goodwill) 42.2M USD -19.5%
Goodwill 0 USD
Other Assets, Noncurrent 1.2M USD -44.9%
Assets 124M USD +5.15%
Accounts Payable, Current 10.6M USD +2.78%
Employee-related Liabilities, Current 3.13M USD -32%
Accrued Liabilities, Current 38.2M USD +0.06%
Liabilities, Current 63.1M USD +1.34%
Long-term Debt and Lease Obligation 10.9M USD +0.17%
Operating Lease, Liability, Noncurrent 985K USD +70.7%
Other Liabilities, Noncurrent 4.92M USD +8.59%
Liabilities 101M USD -0.92%
Retained Earnings (Accumulated Deficit) -334M USD -4.24%
Stockholders' Equity Attributable to Parent 19M USD -31.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 32.2M USD -33.5%
Liabilities and Equity 124M USD +5.15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -211K USD +97.7%
Net Cash Provided by (Used in) Financing Activities -2.73M USD -120%
Net Cash Provided by (Used in) Investing Activities -76K USD -281%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 8.98M shares +50.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.02M USD -168%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.8M USD +3.24%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.36M USD +141%
Deferred Tax Assets, Valuation Allowance 137M USD -0.51%
Deferred Tax Assets, Gross 137M USD -0.88%
Operating Lease, Liability 1.12M USD -13%
Depreciation 100K USD -50%
Lessee, Operating Lease, Liability, to be Paid 2.2M USD -16.1%
Property, Plant and Equipment, Gross 1.25M USD -55.8%
Operating Lease, Liability, Current 137K USD -80.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 331K USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year One 309K USD -68.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +10%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 386K USD -30.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 386K USD +2.39%
Deferred Tax Assets, Operating Loss Carryforwards 120M USD +0.51%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 518K USD -60.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 358K USD -7.25%
Operating Lease, Payments 168K USD -53.3%
Additional Paid in Capital 353M USD +1.38%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 3.68M USD 0%
Depreciation, Depletion and Amortization 2.23M USD -3.09%
Deferred Tax Assets, Net of Valuation Allowance 252K USD -66.9%
Share-based Payment Arrangement, Expense 576K USD -80.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%